Cohort Studyhigh evidence
Opioid agonist treatment and risk of mortality in French primary care: a nationwide, retrospective cohort study.
The Lancet. Public health·July 1, 2026·PMID 42335912
Why it mattersProvides robust real-world evidence that OAT, especially buprenorphine, is strongly associated with reduced mortality in a primary care setting where buprenorphine is widely used. Reinforces the life-saving role of OAT and supports expanding access in general medical practice.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled